|
G |
DAO |
D-amino acid oxidase |
decreases activity |
EXP |
Chlorpromazine results in decreased activity of DAO protein |
CTD |
PMID:18615285 |
|
NCBI chr14:41,931,549...41,950,628
Ensembl chr14:41,931,541...41,950,633
|
|
G |
FMO1 |
flavin containing dimethylaniline monoxygenase 1 |
increases oxidation |
EXP |
FMO1 protein results in increased oxidation of Chlorpromazine |
CTD |
PMID:6439199 |
|
NCBI chr 9:63,860,957...63,895,086
Ensembl chr 9:63,868,064...63,895,076
|
|
|
G |
EDN1 |
endothelin 1 |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of EDN1 protein 1,3-ditolylguanidine inhibits the reaction [Cocaine results in increased expression of EDN1 protein]; Haloperidol inhibits the reaction [Cocaine results in increased expression of EDN1 protein] |
CTD |
PMID:9714087 |
|
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions |
EXP |
Haloperidol inhibits the reaction [Cocaine results in increased expression of EDN1 protein] |
CTD |
PMID:9714087 |
|
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
|
G |
HTR2C |
5-hydroxytryptamine receptor 2C |
affects binding multiple interactions |
EXP |
mesulergine binds to HTR2C protein 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine inhibits the reaction [mesulergine binds to HTR2C protein] |
CTD |
PMID:11927170 |
|
NCBI chr X:94,053,415...94,313,352
Ensembl chr X:94,053,456...94,313,355
|
|